Cardiovascular effects of hemoglobin response in patients receiving epoetin alfa and oral iron in heart failure with a preserved ejection fraction

BACKGROUND: Previous data from a recently conducted prospective, single blind randomized clinical trial among community dwelling older patients with heart failure with a preserved ejection fraction (HFPEF) and anemia randomized to treatment with epoetin alfa (erythropoiesis-stimulating agents, ESA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Vullaganti, Sirish, Goldsmith, Jeff, Teruya, Sergio, Alvarez, Julissa, Helmke, Stephen, Maurer, Mathew S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076448/
https://www.ncbi.nlm.nih.gov/pubmed/25009558
http://dx.doi.org/10.3969/j.issn.1671-5411.2014.02.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076448/
https://www.ncbi.nlm.nih.gov/pubmed/25009558
http://dx.doi.org/10.3969/j.issn.1671-5411.2014.02.002

Ejemplares similares